To conclude, our integrated research strategies have demonstrated that lncRNA XIST expression is up-regulated in CRC patients who are resistant to 5FU treatment, and closely associated with chemoresponse status to 5-FU treatment. Here, XIST is linked to colorectal carcinoma.